Search

everythinglearnresearchcommunity

for

Search:↓

Men typically shed about 10 hairs in 60 seconds, and this amount doesn't increase with age.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Sudden weight loss can cause significant hair loss, and using colchicine on the skin for psoriasis may be unsafe.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

People with chronic hair shedding had much lower vitamin D levels compared to healthy people.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Long-Acting Platelet Rich Plasma therapy can effectively reduce hair shedding, thicken hair, and promote new growth in women with pattern hair loss.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

COVID-19 infection is highly related to increased hair loss, especially in women.

Anemia increases the risk of hair loss in post-COVID-19 survivors.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.